Semin Thromb Hemost 2005; 31(1): 111-117
DOI: 10.1055/s-2005-863813
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Diet and Aging: Bearing on Thrombosis and Hemostasis

Margaret A. Allman-Farinelli1 , Beryl Dawson2
  • 1Nutrition Consultant, Sydney, Australia
  • 2Department of Nutrition and Dietetics, Balmain Hospital, Balmain, Australia
Further Information

Publication History

Publication Date:
11 February 2005 (online)

ABSTRACT

Diet is one of the environmental factors that influences thrombosis and hemostasis. Macronutrients, micronutrients, and other bioactive food components alter the predisposition to thrombosis. The type and amount of dietary fat has been shown to alter thromboxane A2 production and platelet aggregation, bleeding time, factor VII, fibrinogen, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1). Both epidemiological studies and clinical trials indicate that the very long chain n-3 fatty acids lower thrombotic tendency and risk of heart disease. Other polyunsaturated fats and monounsaturated fat appear to have antithrombotic properties, but further studies are indicated. Hypercaloric diets and those with high glycemic loads are associated with elevations of PAI-1. Moderate consumption of alcohol is associated with decreased platelet aggregation. Low intakes of folate, vitamin B12, and vitamin B6 predispose to hyperhomocysteinemia, and the benefits of supplementation in decreasing vascular disease are under investigation. In a limited number of clinical and laboratory studies, vitamin E has been shown to decrease platelet aggregation and the concentration of PAI-1. Flavonoids and isoflavones appear to inhibit platelet aggregation at pharmacologic concentrations only. Nutritional status frequently declines with aging and may exacerbate the already increased risk for thrombosis. Diet presents an interesting area for research into thrombophilia, but additional work is indicated before specific recommendations are made.

REFERENCES

  • 1 Juhan-Vague I, Alessi M C, Mavri A, Morange P E. Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk.  J Thromb Haemost. 2003;  1 1575-1579
  • 2 Scarabin P Y, Aillaud M F, Amouyel P et al.. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction-the PRIME study.  Thromb Haemost. 1998;  80 749-756
  • 3 Jackson A. Protein. In: Mann J, Truswell AS Essentials of Human Nutrition, 2nd ed. Oxford; Oxford University Press 2002: 55-78
  • 4 Quere I, Pernerger T V, Zittoun J et al.. Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study.  Lancet. 2002;  359 747-752
  • 5 Jenkins D J, Wolever T M, Taylor R H et al.. Glycemic index of foods: a physiological basis for carbohydrate exchange.  Am J Clin Nutr. 1981;  34 362-366
  • 6 Jarvi A, Karlstrom B E, Granfeldt Y E, Bjorck I E, Asp N L, Vessby BO H. Improved glycaemic control and lipid profile and normalized fibrinolytic activity on a low glycaemic index diet in Type 2 diabetes.  Diabetes Care. 1999;  22 10-18
  • 7 Liu S, Willett W. Dietary glycemic load and atherothrombotic risk.  Curr Atheroscler Rep. 2002;  4 454-461
  • 8 Kris-Etherton P M, Harris W S, Appel L J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.  Arterioscler Thromb Vasc Biol. 2003;  23 20-31
  • 9 Allman-Farinelli M A, Hall D, Kingham K, Pang D, Petocz P, Favaloro E J. Comparison of the effects of two low fat diets with different α-linolenic:linoleic acid ratios on coagulation and fibrinolysis.  Atherosclerosis. 1999;  142 159-168
  • 10 Hansen J, Grimsgaard S, Nordoy A, Bonaa K H. Dietary supplementation with highly purified eicosapentaenoic acid and docosahexaenoic acid does not influence PAI-1 activity.  Thromb Res. 2000;  98 123-132
  • 11 Li D, Sinclair A, Wilson A et al.. Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men.  Am J Clin Nutr. 1999;  69 872-882
  • 12 Smith R D, Kelly C N, Fielding B A et al.. Long term monounsaturated fatty acid diets reduce platelet aggregation in healthy young subjects.  Br J Nutr. 2003;  90 597-606
  • 13 Lopez-Segura F, Velasco F, Lopez-Miranda J et al.. Monounsaturated fatty acid-enriched diet deceases plasma plasminogen activator type-1.  Arterioscler Thromb Vasc Biol. 1996;  16 82-88
  • 14 Kelly F D, Sinclair A J, Mann N J, Turner A H, Abedin L, Li D. A stearic acid-rich diet improves thrombogenic and atherogenic risk factor profiles in healthy males.  Eur J Clin Nutr. 2001;  55 88-96
  • 15 Marckmann P, Bladbjerg E-M, Jespersen J. Diet and blood coagulation factor VII-a key protein in arterial thrombosis.  Eur J Clin Nutr. 1998;  52 75-84
  • 16 Goldberg I J, Mosca L, Piano M R, Fisher E A. Wine and your heart.  Stroke. 2001;  32 591-594
  • 17 Freedman J E, Parker C, Li L et al.. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release.  Circulation. 2001;  103 2792-2798
  • 18 Ernst E, Resch K L. Therapeutic interventions to lower plasma fibrinogen concentration.  Eur Heart J. 1995;  16(suppl) 47-53
  • 19 Hendricks HF J, Veenstra J, Velthuis-te Weirik EJ M, Schaafsma G, Kluft C. Effect of moderate doses of alcohol with evening meal on fibrinolytic factors.  BMJ. 1994;  308 1003-1006
  • 20 Boushey C J, Beresford S A, Omenn G S, Motulsky G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes.  JAMA. 1995;  274 1049-1057
  • 21 Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials.  BMJ. 1998;  316 894-898
  • 22 Cattaneo M, Lombardi R, Lecchi A, Bucciarelli P, Mannucci P M. Low plasma levels of vitamin B6 are independently associated with a heightened risk of deep-vein thrombosis.  Circulation. 2001;  104 2442-2446
  • 23 Robinson K, Mayer E L, Miller D P et al.. Hyperhomocysteinemia and low pyridoxal phosphate. Common independent reversible risk factors for coronary artery disease.  Circulation. 1995;  92 2825-2830
  • 24 Selhub J, Jacques P F, Wilson P W, Rush D, Rosenberg I H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.  JAMA. 1993;  270 2693-2698
  • 25 Brown S L, Sobel B E, Fujii S. Attenuation of the synthesis of plasminogen activator inhibitor type 1 by niacin. A potential link between lipid lowering and fibrinolysis.  Circulation. 1995;  92 767-772
  • 26 Mehta J, Li D, Mehta J L. Vitamins C and E prolong time to arterial thrombosis in rats.  J Nutr. 1999;  129 109-112
  • 27 Van Giezen JJ J, Boon G DIA, Jansen J WCM, Bouma B N. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (tPA) activity and inhibits venous thrombosis.  Thromb Haemost. 1993;  69 381-386
  • 28 Antoniades C, Tousoulis D, Tentolouris C et al.. Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers.  Thromb Haemost. 2003;  89 990-995
  • 29 Devaraj S, Chan AV C, Jialal I. α-Tocopherol supplementation decreases plasminogen activator inhibitor-1 and P selectin levels in type 2 diabetic patients.  Diabetes Care. 2002;  25 524-529
  • 30 Freedman J E, Keaney J F. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity.  J Nutr. 2001;  131 374S-377S
  • 31 Truswell AS T. Vitamins D and K. In: Mann J, Truswell AS Essentials of Human Nutrition, 2nd ed. Oxford; Oxford University Press 2002: 254-258
  • 32 Rajaram S. The effect of vegetarian diet, plant foods, and phytochemicals on hemostasis and thrombosis.  Am J Clin Nutr. 2003;  78(suppl) 552S-558S
  • 33 Koo K L, Ammit A J, Tran V H, Duke C C, Roufogalis B D. Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation.  Thromb Res. 2001;  103 387-397
  • 34 Reuben D B. Why do physicians fail to recognize and treat malnutrition in older persons?.  J Am Geriatr Soc. 1991;  39 1139-1140
  • 35 Wahlqvist M L, Savige G S, Lukito W. Nutritional disorders in the elderly.  Med J Aust. 1995;  163 376-381
  • 36 Lipski P S. Undernutrition in the elderly: a cause for concern.  Mod Med Austr. 1993;  36 108-120Q11
  • 37 Morley J E. Anorexia in older persons: epidemiology and optimal treatment.  Drugs Aging. 1996;  8 134-155
  • 38 Rosenberg I H, Roubenoff R. Stalking sarcopenia.  Ann Intern Med. 1995;  123 727-728
  • 39 Detsky A S, Smalley P S, Chang J. Is this patient malnourished?.  JAMA. 1994;  271 54-58
  • 40 Waitzberg D L, Correia M I. Nutritional assessment in the hospitalized patient.  Curr Opin Clin Nutr Metab Care. 2003;  6 531-538
  • 41 Delmi M, Rapin C H, Bengoa J M, Delmas P D, Vasey H, Bonjour J P. Dietary supplementation in elderly patients with fractured neck of femur.  Lancet. 1990;  335 1013-1016
  • 42 Fiatarone M A, O'Neill E F, Ryan N D et al.. Exercise training and nutritional supplementation for physical frailty in very elderly people.  N Engl J Med. 1994;  330 1769-1775
  • 43 Di Minno G, Piemontino U, Cerbone A M. Nutrition and thrombogenic factors.  Nutr Metab Cardiovasc Dis. 1999;  9(suppl) 16-20

Beryl Dawson

Department of Nutrition and Dietetics, Balmain Hospital

Booth Street, Balmain, 2041, Australia

Email: beryl.dawson@email.cs.nsw.gov.au

    >